Search Results - "VIRKAMAKI, Antti"

Refine Results
  1. 1

    High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care by Metsärinne, Kaj, Bröijersen, Anders, Kantola, Ilkka, Niskanen, Leo, Rissanen, Aila, Appelroth, Tina, Pöntynen, Nora, Poussa, Tuija, Koivisto, Veikko, Virkamäki, Antti

    Published in Primary care diabetes (01-02-2015)
    “…Abstract Objective To examine the prevalence of chronic kidney disease (CKD) and related cardiovascular morbidity in a cross-sectional population in patients…”
    Get full text
    Journal Article
  2. 2

    Improved control of blood pressure and albuminuria among patients with type-2 diabetes in Finnish open care by Varis, Juha, Metsärinne, Kaj, Koivisto, Veikko, Niskanen, Leo, Rissanen, Aila, Virkamäki, Antti, Appelroth, Tina, Pöntynen, Nora, Poussa, Tuija, Kantola, Ilkka

    Published in Blood pressure (01-04-2017)
    “…Risk of cardiovascular events within the diabetic population has decreased and survival increased with patients living longer and thus facing the development…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The activation of hepatic and muscle polyamine catabolism improves glucose homeostasis by Koponen, Taina, Cerrada-Gimenez, Marc, Pirinen, Eija, Hohtola, Esa, Paananen, Jussi, Vuohelainen, Susanna, Tusa, Maija, Pirnes-Karhu, Sini, Heikkinen, Sami, Virkamäki, Antti, Uimari, Anne, Alhonen, Leena, Laakso, Markku

    Published in Amino acids (01-02-2012)
    “…The mitochondrial biogenesis and energy expenditure regulator, PGC-1α, has been previously reported to be induced in the white adipose tissue (WAT) and liver…”
    Get full text
    Journal Article
  5. 5

    Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle by Patti, M E, Virkamäki, A, Landaker, E J, Kahn, C R, Yki-Järvinen, H

    Published in Diabetes (New York, N.Y.) (01-08-1999)
    “…Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. M E…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus by MÄKIMATTILA, S, VIRKAMÄKI, A, GROOP, P.-H, COCKCROFT, J, UTRIAINEN, T, FAGERUDD, J, YKI-JÄRVINEN, H

    Published in Circulation (New York, N.Y.) (15-09-1996)
    “…We explored whether chronic hyperglycemia is associated with defects in endothelium-dependent vasodilatation in vivo and whether defects in the hemodynamic…”
    Get full text
    Journal Article
  8. 8

    Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM by YKI-JÄRVINEN, H, DANIELS, M. C, VIRKAMÄKI, A, MÄKIMATTILA, S, DEFRONZO, R. A, MCCLAIN, D

    Published in Diabetes (New York, N.Y.) (01-03-1996)
    “…Overactivity of the hexosamine pathway mediates glucose-induced insulin resistance in rat adipocytes. Glutamine:fructose-6-phosphate amidotransferase (GFA) is…”
    Get full text
    Journal Article
  9. 9

    Occurrence and biological properties of a common genetic variant of luteinizing hormone by Haavisto, A M, Pettersson, K, Bergendahl, M, Virkamäki, A, Huhtaniemi, I

    “…We have characterized the frequency and selected biological properties of a variant form of LH caused by two point mutations in the gene of the LH…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart by A Virkamäki, H Yki-Järvinen

    Published in Diabetes (New York, N.Y.) (01-05-1999)
    “…Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: Evidence from the PREDICTIVE™ study by Niskanen, Leo, Virkamäki, Antti, Hansen, Jes B, Saukkonen, Tero

    Published in Diabetes research and clinical practice (01-11-2009)
    “…Abstract The relationship between fasting glucose (FG) variability and nocturnal hypoglycemia was assessed using longitudinal data from PREDICTIVE™, the…”
    Get full text
    Journal Article
  16. 16

    Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity by Korsheninnikova, Elena, Seppälä-Lindroos, Anneli, Vehkavaara, Satu, Goto, Takashi, Virkamäki, Antti

    Published in Diabetes/metabolism research and reviews (01-05-2002)
    “…Background Insulin signaling is impaired in the skeletal muscle of obese subjects but whether defects in skeletal muscle insulin signaling also characterize…”
    Get full text
    Journal Article
  17. 17

    Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women by Vehkavaara, S, Silveira, A, Hakala-Ala-Pietilä, T, Virkamäki, A, Hovatta, O, Hamsten, A, Taskinen, M R, Yki-Järvinen, H

    Published in Thrombosis and haemostasis (2001)
    “…We compared the effects of oral estradiol (2 mg), transdermal estradiol (50 microg), and placebo on measures of coagulation, fibrinolysis, inflammation and…”
    Get more information
    Journal Article
  18. 18

    Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women by VEHKAVAARA, Satu, HAKALA-ALA-PIETILÄ, Tiina, VIRKAMÄKI, Antti, BERGHOLM, Robert, EHNHOLM, Christian, HOVATTA, Outi, TASKINEN, Marja-Riitta, YKI-JÄRVINEN, Hannele

    Published in Circulation (New York, N.Y.) (28-11-2000)
    “…We determined whether the vascular effects of estradiol depend on the route of administration by comparing the effects of oral estradiol and transdermal…”
    Get full text
    Journal Article
  19. 19

    Activation of the Hexosamine Pathway by Glucosamine in Vivo Induces Insulin Resistance in Multiple Insulin Sensitive Tissues by Virkamäki, Antti, Daniels, Marc C., Hämäläinen, Sari, Utriainen, Tapio, McClain, Don, Yki-Järvinen, Hannele

    Published in Endocrinology (Philadelphia) (01-06-1997)
    “…Abstract We determined the effect of infusion of glucosamine (GlcN), which bypasses the rate limiting reaction in the hexosamine pathway, on insulin-stimulated…”
    Get full text
    Journal Article
  20. 20

    A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes by Mauvais-Jarvis, F, Virkamaki, A, Michael, M D, Winnay, J N, Zisman, A, Kulkarni, R N, Kahn, C R

    Published in Diabetes (New York, N.Y.) (01-12-2000)
    “…A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. F Mauvais-Jarvis , A…”
    Get full text
    Journal Article